investordatabase.org

Bioventure Management GmbH

bioventure.de Direct investor

Bioventure structures club deals that invest in early-stage biopharmaceutical and life-science companies, with active management of each participation. It targets semi-professional and professional investors with a minimum participation of 200,000 euros.

Bioventure Management GmbH is a deal-by-deal club or syndicate headquartered in Germany, founded in 2001. It invests directly in companies, at seed, in biotechnology, genome editing, medical technology and cell therapies. Its stated cheque size is Mindestbeteiligung 200.000 Euro.

“Wir investieren in Biotechnologie, Medizintechnik und Zelltherapien mit klarem Impact und exzellentem Renditepotenzial.”

— Bioventure Management GmbH, own website
Layer
Direct investor
Type
Deal-by-deal club / syndicate
Stage
Seed
Headquarters
Germany
Sectors
biotechnology, genome editing, medical technology, cell therapies, nutrition and metabolic medicine
Cheque size
Mindestbeteiligung 200.000 Euro
Founded
2001

Team, as Bioventure Management GmbH publishes it

  • Dr. Erik Hoppe Gründer & Partner Bioventure
  • Nico Straub Partner
  • Simon Kaltenhäuser Head of Finance and Investment Controlling
  • Dr. Ákos Farkas Principal Scientist
  • Tobias Kintzel Investor Relations & Marketing Manager

Names and roles exactly as listed on bioventure.de. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page Bioventure Management GmbH publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 16400 · added 2026-10-26 · link last verified 2026-10-26 · confidence high

Similar investors

Listed under